---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-162939"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2025-07-23T23:59:59+00:00"
generated_at: "2026-05-18T03:29:36.642799+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Verrica Pharmaceuticals Announces 1-for-10 Reverse Stock Split Effective July 24, 2025

## Summary
- Verrica Pharmaceuticals (VRCA) filed a Certificate of Amendment to effect a 1-for-10 reverse stock split, authorized by stockholders on June 5, 2025.
- The reverse stock split becomes effective at 5:00 p.m. ET on July 24, 2025; trading on Nasdaq on a split-adjusted basis begins July 25, 2025.
- Outstanding shares will be reduced from approximately 92.5 million to about 9.25 million, with no fractional shares issued; cash paid in lieu.
- Proportionate adjustments will be made to exercise price and number of shares issuable under stock options, warrants, and equity plans.
- The new CUSIP number for VRCA common stock post-split is 92511W207.

## SEC filing metadata
- accession: 0001193125-25-162939
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2025-07-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312525162939/0001193125-25-162939-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312525162939/d30630d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-162939
- JSON: https://secwatch.observer/filing/0001193125-25-162939.json
- Plain text: https://secwatch.observer/filing/0001193125-25-162939.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.